Novartis' malaria drug for babies wins world-first approval

8th July 2025 Uncategorised 0

Novartis and a Swiss nonprofit have made history, scoring the world’s first approval for a medicine to treat babies who are infected with malaria. The nod is for a new formulation of Coartem, which is also known commercially in come countries as Riamet.

More: Novartis' malaria drug for babies wins world-first approval
Source: fierce